Brian McKernan
BM
Brian McKernan
CEO at Predicta Biosciences
Rate
About
Brian McKernan is a seasoned biotech entrepreneur with a track record of successful startups. He is currently the CEO of Predicta Biosciences, a precision oncology company. McKernan has also held CEO positions at BioVexis, Fluent BioSciences (acquired by Illumina), Nusano, and Medicinal Genomics. He holds an MBA in Finance from Columbia Business School and a BA from Bucknell University.
Frequently asked
Who is Brian McKernan?
Brian McKernan is a seasoned biotech entrepreneur with a track record of successful startups. He is currently the CEO of Predicta Biosciences, a precision oncology company. McKernan has also held CEO positions at BioVexis, Fluent BioSciences (acquired by Illumina), Nusano, and Medicinal Genomics. He holds an MBA in Finance from Columbia Business School and a BA from Bucknell University.
What is Brian McKernan's current role?
Brian McKernan is currently CEO at Predicta Biosciences.
Comments
No comments yet. Be the first to share your take.
Profile
About Brian McKernan
Brian McKernan is CEO at Predicta Biosciences. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.